[An incident of toadstool poisoning]

Area of Science:

• Toxicology
• Clinical Medicine
• Mycology

Background:

• Mushroom poisoning poses a significant public health risk, often due to misidentification of wild fungi.
• Accurate identification and timely clinical management are crucial for patient outcomes.

Observation:

• A poisoning incident in Shandong in July 2018 involved residents consuming a poisonous mushroom identified as scaled white goose cream (H1).
• Two patients presented with severe gastrointestinal symptoms including nausea, vomiting, abdominal pain, and diarrhea.
• Subsequent liver damage was observed in both patients.

Findings:

• The identified mushroom species was confirmed as the causative agent of the poisoning.
• Clinical manifestations included acute gastrointestinal distress and subsequent hepatotoxicity.
• One patient experienced a life-threatening complication of acute pulmonary embolism, successfully treated with interventional thrombolysis.

Implications:

• This case highlights the importance of public awareness regarding poisonous mushroom identification, specifically the scaled white goose cream.
• Prompt medical intervention and supportive care are vital for managing severe mushroom poisoning and its complications.
• Further research into the specific toxins and treatment protocols for scaled white goose cream poisoning may improve patient survival rates.